Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors

Figure 4

Coregistered PET and MR images from individual with anaplastic oligodendroglioma WHO grade III (participant #14). ((a)–(d)) MR images obtained at the time of PET study. (a) T1-weighted MR image with contrast (Gadolinium) enhancement; (b) T2-weighted MR image; (c) Apparent Diffusion Coefficient (ADC) diffusion-weighted MR image; (d) Cerebral Blood Volume (CBV) perfusion-weighted MR image; (e) AG PET image; (f) CMRGlu PET image; (g) CMRO₂ PET image. (h) CBF PET image; (i) T2-weighted MR image 1 day after surgery (2 days after the PET study); ((j)–(l)) Follow-up T1-weighted images with contrast (Gadolinium) enhancement obtained 2 days (j), two months (k), and 14 months (l) after the PET study.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)